Travel Vaccines Market 2020: Global Analysis, Industry Growth, Current Trends and Forecast till 2021

“Travel Vaccines – Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2026”

PUNE, MAHARASHTRA, INDIA, December 1, 2020 /EINPresswire.com/ — Updated Research Report of Travel Vaccines Market 2020-2026:

Summary: Wiseguyreports.Com Adds “Travel Vaccines – Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2026” To Its Research Database.

Overview

The Global Travel Vaccines Market is expected to grow from USD 5,108.52 Million in 2019 to USD 8,579.99 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.02%.

Market Segmentation & Coverage:

This research report categorizes the Travel Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:

On the basis of Composite, the Travel Vaccines Market is examined across Combination Vaccines and Mono Vaccine.

On the basis of Type, the Travel Vaccines Market is examined across Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, Inactive Vaccines, Recombinant Vector Vaccines, Subunit Vaccines, and Toxoid Vaccines.

On the basis of Geography, the Travel Vaccines Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is examined across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is examined across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is examined across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Travel Vaccines market is segmented into
Cholera
Rabies Vaccine
Hepatitis
Typhoid

Segment by Application
Hospital
Clinic

@Get Free Sample Copy of the Travel Vaccines Market Research Report:https://www.wiseguyreports.com/sample-request/4806748-global-travel-vaccines-market-research-report-2020

Global Travel Vaccines Market: Regional Analysis
The Travel Vaccines market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Travel Vaccines market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Global Travel Vaccines Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Travel Vaccines market include:
GSK
Sanofi
Merck
Pfizer
Jintan
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen

Key questions answered in the report:
What will the market growth rate of Travel Vaccines market in 2026?
What are the key factors driving the global Travel Vaccines market?
What are sales, revenue, and price analysis of top manufacturers of Travel Vaccines market?
Who are the distributors, traders and dealers of Travel Vaccines market?
Who are the key manufacturers in Travel Vaccines market space?
What are the Travel Vaccines market opportunities and threats faced by the vendors in the global Travel Vaccines market?
What are sales, revenue, and price analysis by types and applications of Travel Vaccines market?
What are sales, revenue, and price analysis by regions of Travel Vaccines market?
What are the market opportunities, market risk and market overview of the Travel Vaccines market?

@Have Any Query? Ask Our Expert:https://www.wiseguyreports.com/enquiry/4806748-global-travel-vaccines-market-research-report-2020

Major Key Points in Table of Content

1 Travel Vaccines Market Overview

2 Global Travel Vaccines Market Competition by Manufacturers

3 Travel Vaccines Retrospective Market Scenario by Region

5 Global Travel Vaccines Historic Market Analysis by Application

6 Company Profiles and Key Figures in Travel Vaccines Business

7 Travel Vaccines Manufacturing Cost Analysis

8 Marketing Channel, Distributors and Customers

9 Market Dynamics

10 Global Market Forecast

Continued………

ABOUT US:

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Note:

Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

Vitamins and Dietary Supplement Market 2020: Global Analysis, Industry Growth, Current Trends and Forecast till 2026

“Vitamins and Dietary Supplement – Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2021”

PUNE, MAHARASHTRA, INDIA, December 1, 2020 /EINPresswire.com/ — Updated Research Report of Vitamins and Dietary Supplement Market 2020-2021:

Wiseguyreports.Com Adds “Vitamins and Dietary Supplement – Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2021” To Its Research Database.

Overview

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Vitamins and Dietary Supplement market is segmented into
Vitamins
Minerals
Other

Segment by Application
Men
Women
Pregnant woman
Elderly
Other

Global Vitamins and Dietary Supplement Market: Regional Analysis
The Vitamins and Dietary Supplement market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Vitamins and Dietary Supplement market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

@Get Free Sample Copy of the Vitamins and Dietary Supplement Market Research Report:https://www.wiseguyreports.com/sample-request/6066394-global-vitamins-and-dietary-supplement-market-outlook-2021

Global Vitamins and Dietary Supplement Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Vitamins and Dietary Supplement market include:
Amway
INFINITUS
Herbalife Nutrition
DEEJ
Usana
Blackmores
PERFECT (CHINA)
Swisse
China New Era Group
By-health
Suntory
Pfizer
Beijing Tong Ren Tang
Shanghai Pharma
TIENS
GNC
Real Nutriceutical
Southernature

Key questions answered in the report:
What will the market growth rate of Vitamins and Dietary Supplement market in 2021?
What are the key factors driving the global Vitamins and Dietary Supplement market?
What are sales, revenue, and price analysis of top manufacturers of Vitamins and Dietary Supplement market?
Who are the distributors, traders and dealers of Vitamins and Dietary Supplement market?
Who are the key manufacturers in Vitamins and Dietary Supplement market space?
What are the Vitamins and Dietary Supplement market opportunities and threats faced by the vendors in the global Vitamins and Dietary Supplement market?
What are sales, revenue, and price analysis by types and applications of Vitamins and Dietary Supplement market?
What are sales, revenue, and price analysis by regions of Vitamins and Dietary Supplement market?
What are the market opportunities, market risk and market overview of the Vitamins and Dietary Supplement market?

@Have Any Query? Ask Our Expert:https://www.wiseguyreports.com/enquiry/6066394-global-vitamins-and-dietary-supplement-market-outlook-2021

Major Key Points in Table of Content

1 Vitamins and Dietary Supplement Market Overview

2 Global Vitamins and Dietary Supplement Market Competition by Manufacturers

3 Vitamins and Dietary Supplement Retrospective Market Scenario by Region

5 Global Vitamins and Dietary Supplement Historic Market Analysis by Application

6 Company Profiles and Key Figures in Vitamins and Dietary Supplement Business

7 Vitamins and Dietary Supplement Manufacturing Cost Analysis

8 Marketing Channel, Distributors and Customers

9 Market Dynamics

10 Global Market Forecast

Continued………

ABOUT US:

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Note:

Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

SCHC, a Top-rated Trauma and PTSD Treatment Centre in British Columbia Canada, Announces New Sleep Treatment Options

Georgia Strait Women's Clinic Announces Launch of Website for Drug Rehab, Alcohol Treatment, and Trauma

British Columbia, Canada

Sunshine Coast Health Centre (SCHC) is a best-in-class drug, alcohol, and trauma treatment centre located in Powell River, BC, Canada.

Restful sleep is fundamental to good mental health.”

— Casey Jordan

VANCOUVER, BC, USA, November 30, 2020 /EINPresswire.com/ — Sunshine Coast Health Centre (SCHC), a best-in-class trauma and PTSD treatment program located in Powell River BC Canada, is proud to announce renewed sleep treatment options for its clients. Many clients who come to the center with trauma, PTSD, drug rehab, or alcohol treatment needs may also be experiencing sleep issues. The renewed focus on sleep problems helps clients deal with any interrelated issues that involve sleep problems.

"Restful sleep is fundamental to good mental health," explained Casey Jordan, Chief Marketing Officer. "Our renewed focus on sleep emphasizes how our treatment for PTSD, trauma, and substance abuse is done in a holistic way for each client. We work with the client to treat their mental health as a whole, not just their PTSD or trauma."

Interested persons can read more about the Centre's sleep options at https://www.sunshinecoasthealthcentre.ca/sleep-hygiene/. That page explains as follows. Sleep disorders are common in addiction recovery. In fact, many clients struggle with obstructive sleep apnea (OSA). OSA is both a common and chronic condition that many people experience. It is estimated that approximately 80% of people with obstructive sleep apnea are undiagnosed. The prevalence of OSA is higher among people with other health issues such as hypertension, obesity, congestive heart failure, Type 2 Diabetes, and other conditions. Symptoms can include snoring, tiredness throughout the day, high blood pressure, morning headaches, breathing issues while sleeping (observed and reported by others), as well as a high body weight and BMI. If a client reports sleep apnea and other sleep disorders upon arrival, the Centre will work with them to address any issues. There are a wide variety of options for treating snoring and/or sleep apnea. In collaboration with Careica Health, the Centre has several methods to choose from to make restful sleep a goal of treatment.

Those interested in learning more about the trauma and/or PTSD services can visit the information page at https://www.sunshinecoasthealthcentre.ca/occupational-trauma-ptsd/, and it should also be noted that the Centre focuses on men only in its drug rehabilitation and alcohol treatment services provided at Powell River, BC. Women who suffer from these issues can visit the Centre's sister website at https://georgiastraitwomensclinic.ca/, which offers best-in-class therapy options for Canadian women. It is also located in Powell River, BC.

ABOUT SUNSHINE COAST HEALTH CENTRE

Sunshine Coast Health Centre (http://www.sunshinecoasthealthcentre.ca) is a 47-bed drug and alcohol rehabilitation facility exclusively designed for men, officially opened on the 15th of March 2004. The Centre has a philosophy of care that goes beyond just addiction to include personal transformation based on three key therapeutic principles: interpersonal relatedness, self definition (autonomy & competence), and intrinsic motivation. The Centre offers both drug rehabilitation and alcohol treatment near Vancouver, BC, but serving patients across Canada, particularly British Columbia and Alberta and cities such as Calgary, Edmonton and Red Deer. Sunshine Coast Health Centre uses a form of drug rehabilitation based on the research of Viktor Frankl and methodology of Paul T.P. Wong, namely 'Meaning ­Centered Therapy'.

Jason McDonald
JM Internet Group
+1 415-655-1071
email us here


Source: EIN Presswire

John P. Wilson, Ph.D., & CEO, Guest Spoke at the National University of Singapore Educating Students on Entrepreneurship

Dr. John Wilson

"I am not into Bioscience, but you gave me a new dimension to be an entrepreneur," states a PhD student regarding John Wilson's speech.

LOS ANGELES, CA, UNITED STATES, November 30, 2020 /EINPresswire.com/ — Dr. John P. Wilson, PhD and CEO of ProtiFi, LLC, made time yet again to educate in a very recent special event. He was invited to be the special guest speaker of the talk, "Academia, Industry and Entrepreneurship: Which is Your Parachute?", to the National University of Singapore (NUS). NUS is ranked consistently as one of the world's top universities and offers the most extensive college degree courses in Singapore. The invite came from Graduate Students Society National University of Singapore(GSS). Most young professionals, such as PhD candidates and students, of the National University of Singapore were in attendance. The call was 7 am ET, 8 pm Singapore time via Zoom on November 25, 2020.

Dr. Wilson has been passionately advocating for the potential and value of entrepreneurship, especially in biotech, for more than a decade. His latest outing was yet again a unanimous success and praised by young professionals at NSU: "Your webinar organized by NUS was exceptionally amazing. I am not into Bioscience, but you gave me a new dimension to be an entrepreneur. I am currently working on a Rural technology solution for India. I am the guy who said "Perseverance". I will remember the word for years to come," praises Gokul M.C, a PhD student at NSU. The response “perseverance” was in reply to Dr. Wilson’s question “What personality trait is most essential to being successful entrepreneur?”.

Dr. Wilson shared his passion and purpose in the journey to do good through entrepreneurship by vigilantly using the gifts we each receive. His own journey began as a child making things to sell in a workshop with his father to supplement the income of his two social worker parents in the farm country of Oregon and led through multiple difficult working experiences. In grad school he nearly died from simultaneous lung infections and meningitis, an experience that left him with first-hand knowledge of the value of health and experience of COVID19 victims. He then went on to the #1 ranked Cold Spring Harbor Laboratory where he developed seminal technologies to enable precision medicine and personalized health, which he launched as ProtiFi, LLC.

"Thanks to GSS, I got to know you. It was very motivational and thank you for sharing your experiences," states Abigail Tan, PhD candidate at NSU.

Dr. Wilson believes entrepreneurship is essential to effecting real change in the many problems of the world and is, for that reason, passionate about education. ProtiFi, LLC, which Dr. Wilson founded, has as part of its broader mission to be “…an active, integral part of the omics community that, through collaboration, education and contribution, strives to advance humanity's scientific understanding." Dr. Wilson’s continued talks fulfill the mission of education.

"I got to know you through a webinar session and it was very inspiring. Thank you for sharing your experiences," concludes Xiaoyang Chen, PhD candidate at NSU.

Dr. Wilson actually gave a very similar talk to the American Medical Student Association via invitation from the New York Institute of Technology (NYIT) on November 17th. The American Medical Student Association, founded in 1950 and based in Washington, D.C., is the oldest and largest independent association of physicians-in-training in the United States. AMSA is a student-governed, national organization.

"Education of our youngest generation about the power of entrepreneurship to make transformative changes can solve the very big problems we face," concludes Dr. Wilson. “In 2008, I founded a 501(c)3 not for profit called NYC Bio which had the goal of facilitating the growth of a biotech cluster through education, networking and collaboration. Fast forward 12 years and while it worked, and I'm still educating because education (or not) is how we make transformative changes (or not). Giving some direction and advice to our future generations who could, by example, cure cancer or malaria, is well worth the time. Young people need to know by example that they can chase their passions and earn a living in the pursuit of good ends."
————————————————–

Dr. John Wilson

John Wilson, Ph.D., is CEO and Co-Founder of ProtiFi, LLC producing solutions for protein and proteomics analysis. He also founded NYC Bio, a non-profit dedicated to collaboration and innovation in biotech. John is “problem solver” and does just that. Having done proteomics since 2001, he got his PhD from The Rockefeller University and joined Cold Spring Harbor Laboratory (CHSL) as a postdoc with Darryl. Together, they’ve made cool technology. John is passionate about R&D that makes a difference.

Aurora DeRose
Boundless Media Inc.
+ +1 951-870-0099
email us here


Source: EIN Presswire

Emil Malak Pens an Op-ed: New antibody resistant coronavirus mutation N493K; Focus should be on testing

Emil Malak, CEO Voip-Pal, well versed in global politics, culture and health

VOIP-PAL CEO Emil Malak

VOIP-PAL Corporate Logo

CEOCFO Magazine logo

There is an urgent need for continuous testing every three days as well as making COVID-19 testing more widely available through innovative means such as testing vending machines.”

— Emil Malak

WASHINGTON, DC, US, November 30, 2020 /EINPresswire.com/ — CEOCFO Magazine, an independent investment publication that highlights important technologies and companies, today announced it has published an op-ed (https://www.ceocfointerviews.com/emilmalakoped1120.html) by Voip-Pal CEO Emil Malak. Voip-Pal.com Inc., Voip-Pal (OTCQB: VPLM), a Bellevue, Washington based company is an inventor and pioneer of the switching technology now being used by many of the world's largest telecommunication and social networking companies, without which they could not connect Landline phone calls to Internet phone calls. Mr. Malak has other business ventures and is well versed in global politics and culture.

In February of this year (2020), just as the world was waking up to the news that people were fleeing Wuhan China, headed to worldwide destinations with the deadly coronavirus, Mr. Malak wrote his very first Op-ed on the subject. In the title of his article, “A Global Pandemic Has Already Started” Mr. Malak declared the novel coronavirus to be a worldwide pandemic one month before the World Health Organization did. Since then we have seen several of Mr. Malek’s predictions on the virus come true.

In his most recent op-ed, Mr. Malak discussed the new antibody resistant coronavirus mutation N493K. “The neutralizing antibodies that patients develop after being infected with a virus or following vaccination are not proving to be effective against this new mutant. The N439K mutation so-far is proving to be resistant to antibodies.

He continued, “N439K has already been identified in twelve countries and is increasing infection rates in the United States and Europe. As a result, within the next four weeks we could potentially see death rates increase. Authors of a recent study on the new coronavirus mutant conclude their findings could have consequences, not only on the efficacy of emerging vaccines but also the efficacy of antibody therapeutics.”
https://www.biorxiv.org/content/10.1101/2020.11.04.355842v1

With studies such as the one by The University of Vermont Medical Center yet to be done, Mr. Malak who is very pro-vaccine and believes they save lives cautioned, “I have the utmost respect for politicians on both sides of the aisle that have dedicated their efforts into eradicating the coronavirus. One of the challenges is there are still too many unknowns before we can roll out a safe vaccine solution. Do neutralizing antibodies indeed vanish within a few months? Will antibody dependent enhancement (ADE) put those vaccinated in danger? Could a vaccinated person, thinking they are immune to COVID-19 become an asymptomatic carrier and spread the virus? How many doses of the vaccine will people need per year? Some suggest three of four doses per year to be safe. What about side effects? Will spike protein mutations complicate matters?”
https://www.uvmhealth.org/medcenter/clinical-trials-and-research/COVID-19-vaccine-study#
https://www.virology.ws/2009/07/24/virus-neutralization-by-antibodies/

Malak has repeatedly warned in his op-eds over the past nine months about the need to gather adequate data of at least two years before allowing a vaccine to go to the market. Recalling the mistakes of the 1960’s Thalidomide tragedy that led to tens of thousands of children born with birth defects, Malak wrote, “We need to learn from these tragedies and never repeat the same mistakes. Rushing into any drug or vaccine could lead to catastrophic consequences.”

Pointing to a study by Danish researches, Mr. Malak discusses another concern in the possibility that today’s vaccine may not work tomorrow because of virus mutation, “Researchers have documented at least two mutations of the coronavirus. In one instance the genetic sequence within the spike protein changed the position of the “614 G” aspartic acid (contains an amino acid and a carboxylic acid) to an “amino acid glycine.” That single change within the spike protein created a new COVID-19-2.0, far more contagious and deadly than the original. The second mutation was recently discovered in the mink farms of Denmark; two amino acid mutations within the spike protein. It is valid to question whether a vaccine would be effective after a mutation takes place in the spike protein. We do not know when, nor how frequently a mutation will take place, rendering the vaccine ineffective each time. Another important question that needs to be answered is how effective any COVID-19 vaccine will be on a mutated strain of the virus; a COVID-2.0.”

Mr. Malak continues, “As a result of this new virus all of Denmark’s 17 million farmed minks in their 400 mink farms are being destroyed and 240 or more mink farm workers are currently infected. This latest development provides even more reason why the focus should be on developing more effective therapeutics,” said Mr. Malak.
https://www.nytimes.com/2020/11/04/health/covid-mink-mutation.html

Mr. calls for what he calls, “The hammer and the dance” – for a new non-political task force. “It is necessary to form a national scientific advisory committee that is free from all political influence. The committee would provide two televised updates per week to advise the public of the facts regarding the coronavirus, its spread and what actions need to be taken by each state.”

Below is Mr. Malak’s proposal:
The Hammer – Europe is headed back to total lockdown, referred to as the “hammer” because of the resurgence of coronavirus cases. The virus is back in Europe vigorously, leading government officials to once again shutdown their economies. This radical action will be devastating to businesses and to the overall mental and physical health of Europeans and will hopefully be limited to a very short period.

The Dance – During the hammer period certain actions must be taken to get people back to work:
1. There is an urgent need for continuous testing every three days as well as making COVID-19 testing more widely available through innovative means such as testing vending machines that provide rapid results in one minute. Those that test negative are free to go to work, restaurants and live their lives normally. Those who test positive will seek medical attention and self-quarantine. More simple, rapid self-testing kits are needed.
2. Reconfigure workplaces providing the means for social distancing, disinfectants and mask wearing indoors.
3. Limit the size of indoor gatherings.
4. Indoor locations like restaurants, bars, and conference centers etc. could be retrofitted with air conditioning systems that burn out the virus during circulation cycles.
5. Close down tattoo parlors, massage parlors and prostitution businesses. Those with addictions should be treated in proper medical facilities.

People that do not adjust to the new norms necessary to deal with the virus will be leaving themselves vulnerable to potential infection and risks associated with the virus which includes death.

Malak, who has many years of experience dealing with the U.S. patent system hinted he may be writing a future article on the current state of patents in the United States saying, “Unfortunately, owning a U.S. patent today can be meaningless. It is no longer an asset but a liability.”

Bud Wayne
CEOCFO Magazine
+1 570-851-1745
email us here


Source: EIN Presswire

Allagash partners with Portland-Based Therapy Group to offer Expanded Access to Mental Health Care Services

WellSpace Maine Logo

Allagash contracts directly with WellSpace@Work and thus enables its workers to gain fast, confidential access to our staff who are nearby, available and a good match for a given employee’s issue.”

— Lindy Graham, LCSW and founder of WellSpace Maine

PORTLAND, MAINE, UNITED STATES, November 30, 2020 /EINPresswire.com/ — Allagash Brewing Company, which ranks among the best companies to work for in Maine, has recently launched a pilot program designed to make mental health counseling services more accessible to its workforce.

The program was announced jointly by Allagash and WellSpace@Work, a newly formed division of WellSpace Maine, a Portland-based mental health counseling practice.

In a statement, Celine Frueh, Allagash’s Human Resources Directory, said, “We are collectively experiencing the most stressful experience of our lives during the COVID pandemic at Allagash and throughout the world,” Our team is our number one priority, and essential to our surviving the pandemic. We wanted to put additional support in place for this fall/winter, ensuring that if anyone on the Allagash team wanted support for stress-related issues, they would be able to access it readily. With respect to mental health counseling, there are two general obstacles: finding a therapist, and affording the cost. By partnering with WellSpace@Work, and Allagash paying 100% of the cost, we were able to remove both of those barriers. What we hope to be a lasting effect of this partnership and increased education about mental health is totally normalizing the need for support on this front and removing stigmas about treating mental health challenges as they arise.”

Lindy Graham, a licensed clinical social worker who has been practicing in Portland since 2007 and who began growing WellSpace Maine in 2010, stated, “Through this program, Allagash contracts directly with WellSpace@Work and thus enables its workers to gain fast, and very importantly, confidential access to our staff who are nearby, available, and, a good match for a given employee’s particular issue due to careful upfront assessment. Our therapists know the Maine culture well—something we have found to be important to the employers currently considering Allagash-type programs with us”.

She explained that WellSpace@Work is paid on a fee-for-service basis for a variable, but finite, number of sessions which are carried out at this time via secure telehealth appointments but, post pandemic, will be offered on an in-person basis.

For Allagash, WellSpace@Work has set up a dedicated client-service unit and phone line to smooth the administrative process. It is also providing virtual mental health educational support through “lunch and learn” programs. Thus far, it has conducted a webinar on seasonal affective disorder (SAD) and managing the demands of work and children’s remote learning needs. Other webinars on substance use, parenting babies and toddlers in the pandemic, mindfulness, and healthy eating are in the offing.

###

About WellSpace Maine:

WellSpace Maine, which has offices in Portland and Yarmouth, provides counseling services for children, adolescents, families and couples. It also offers custom-designed counseling programs for employers through WellSpace@Work, as well as a professional training program for clinicians interested in deepening their practice. For more information about WellSpace Maine, please visit www.wellspacemaine.com.

Nancy Marshall
WellSpace@Work
nmarshall@marshallpr.com
Visit us on social media:
Facebook


Source: EIN Presswire

Surgical Light Market To Grow Valuation $3,838 Million By 2026 Growth Opportunities, Demand & Leading Players

 Surgical light Market

Surgical light Market

surgical lights market size was valued at $2,717.5 million in 2018, and is expected to reach $3,838 million by 2026, registering a CAGR of 4.5% to 2026.

Surgical lights Market is expected to reach $3,838 Mn by 2026 North America accounted for the majority of the market share in 2018 and is anticipated to continue this trend during the forecast period.”

— Ashish

PUNE, MAHARASHTRA, UNITED STATES, December 1, 2020 /EINPresswire.com/ — According to the report, the global surgical lights market was estimated at $2.71 billion in 2018, and is projected to garner $3.83 billion by 2026, registering a CAGR of 4.5% from 2019 to 2026. "Surgical Lights Market by Type (Halogen and LED Lights) and Application (Cardiac Surgery, Gynecological Surgery, Neurosurgery, ENT Surgery, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026."

Surgical Lights market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6441

Significant rise in surgical procedures, and surge in technological developments in surgical lights drive the growth of the global surgical lights market. On the other hand, high cost of LED lights restrains the growth to some extent. However, various growth opportunities in emerging economies are expected to create a number of opportunities in the industry.

The cardiac surgery segment to dominate during the estimated period-

Based on application, the cardiac surgery segment accounted for nearly one-fifth of the global surgical lights market revenue in 2018, and is anticipated to maintain the lion's share from 2019 to 2026. In addition, the same segment is expected to grow at the fastest CAGR of 5.3% throughout the forecast period. The increased incidence of cardiovascular disorders and surge in surgical procedures for their treatment have fueled the growth of the segment. The market also analyses segments including gynecological surgery, neurosurgery, and ENT surgery.

The halogen segment to lead the trail till 2026-

Based on type, the halogen segment accounted for more than half of the global surgical lights market share in 2018, and is expected to rule the roost by the end of 2026. This is due to its wide usage in the hospital and ambulatory settings. On the other hand, the LED segment is projected to register the fastest CAGR of 4.6% during 2019–2026.

Inquiry for Buying@ https://www.alliedmarketresearch.com/purchase-enquiry/6441

Key Benefits for Stakeholders:
The surgical lights market share and analysis is based on a comprehensive analysis of key developments in the surgical lights industry.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global surgical lights market.
The study provides an in-depth analysis of the market trends to elucidate the imminent investment pockets.
The global surgical lights market trends are studied from 2018 to 2026.
Information about key drivers, restrains, and opportunities and their impact analysis on the market size is provided.

Surgical lights Market Regional Analysis:

North America (Canada, Mexico)

Europe (Germany, France, Italy, Spain)

Asia-Pacific (Japan, China, India, Australia)

LAMEA (Brazil, Saudi Arabia, South Africa)

This report covers all the essential information required to understand the key developments in the Surgical lights Market and growth trends of each segment and region. It also includes a basic overview and revenue and strategic analysis under the company profile section.

Read More@ https://www.alliedmarketresearch.com/surgical-lights-market-A06076

Surgical lights Market Competitive Analysis:

Steris plc., A-dec Inc., BihlerMED, CV Medical, Skytron, Herbert Waldmann GmbH & Co., Getinge AB, Hill-Rom Services, and S.I.M.E.O.N. Medical GmbH & Co. KG are provided in this report.

Healthcare CRO Services market – Global Opportunities and Forecasts, 2026

Multiple Sclerosis Therapies Market Opportunity & Industry Forecast, 2026

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analyti1cs LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

David Correa
Allied Analytics LLP
+19049962983 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Specialty Pulp and Paper Chemicals Market Advanced Research And Growth Opportunities In Global Industry By 2023

Specialty Pulp and Paper Chemicals Market

Specialty Pulp and Paper Chemicals Market

Specialty pulp and paper chemicals are the raw materials used to produce specialty paper and it reduces the consumption of water and energy.

PORTLAND, OREGON, UNITED STATES, December 1, 2020 /EINPresswire.com/ — According to a new report published by Allied Market Research, titled, "Specialty Pulp and Paper Chemicals Market by Type: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global specialty pulp and paper chemicals market was valued at 15,568 million in 2016, and is projected to reach 22,829 million by 2023, registering a CAGR of 5.6% from 2017 to 2023. In 2016, the functional chemicals segment accounted for approximately one-fifth share of the global market, in terms of value.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4586

Specialty pulp and paper chemicals are the raw materials used to produce specialty paper. These are the integral part of manufacturing process of paper and reduces the consumption of water and energy. It also improves the optical and functional properties of paper such as color, texture, brightness, strength, printing ability, and others during the paper manufacturing process. Some of the specialty paper chemicals include sodium hydrosulfite, hydrogen peroxide, and chlorine, which are used as bleaching agents; sodium silicate, enzymes and various surfactants used in the de-inking process; and alkyl ketene dimer and alkenyl succinic anhydride used for sizing. Specialty paper has wide applications, which includes printing, labeling, and packaging in various sectors such as paper, food, textile, retail, and packaging.

The recycling of paper has gained considerable importance in the global paper industry over the past decade. The increased use of recycled paper results in an increased requirement for specialty pulp and paper chemicals. In addition, the demand for functional chemicals in various applications such as packaging, printing, and decoration is on an increase, thus driving the specialty pulp and paper chemicals market.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4586

The functional chemicals segment of specialty chemicals comprises of different types of dry-strength additives, wet-strength resins, fluorescent whitening, and sizing agents. The wide applications of specialty paper in different sectors demand different characteristics of papers related to its color, brightness, sizing, texture, and others. The use of functional chemicals has increased to meet the needs of the paper manufacturing industry, which contributes to the growth of the specialty pulp and paper chemicals market. However, due to the adverse effects of chemicals on environment and human health stringent regulations are drafted over their usage in manufacturing of specialty paper, which hampers the growth of the market. In addition, fluctuations in the price of raw materials and chemicals required for paper production is expected to restrict the growth of the specialty pulp and paper chemicals market.

Nevertheless, specialty pulp and paper chemicals offer benefits such as improvement in productivity, reduced water, raw materials, and energy consumption that help control the overall cost of operation providing lucrative opportunities for the market in the upcoming years. Moreover, the use of new enzymes in the production of specialty papers is also anticipated to provide great opportunities for the specialty pulp and paper chemicals market during the forecast period.

Interested in Procuring this Report? Visit: https://www.alliedmarketresearch.com/specialty-pulp-and-paper-chemical-market/purchase-options

Key Findings of the Specialty Pulp and Paper Chemicals Market:

• The functional chemical segment is expected to be fastest-growing segment, at an estimated CAGR of 6.3% from 2017 to 2023.
• The bleaching & RCF chemical segment is expected to account for the highest market share and is anticipated to grow at a CAGR of 5.0% from 2017 to 2023.
• Asia-Pacific accounted for largest market share in the global specialty pulp and paper chemicals growing at a CAGR of 7.4%.
• In 2016, the U.S. accounted for the largest market share growing at a CAGR of 4.1%, closely followed by China, which is growing at an estimated CAGR of 7.9% from 2017 to 2023.
• LAMEA is anticipated to grow at a significant CAGR of 5.8%.

In terms of value, Asia-Pacific and LAMEA collectively contributed more than half of the share in the global market in 2016.
The key players operating in specialty pulp and paper chemical market are AkzoNobel N.V., Ashland Inc., Buckman Laboratories International, Inc., BASF SE, Buckman Laboratories International, Inc., Kemira Oyj, SNF Floerger, The Dow Chemical Company, Evonik Industries AG, Nalco Holding Company and Shell Chemicals.

Get detailed COVID-19 impact analysis on the Specialty Pulp And Paper Chemical Market: https://www.alliedmarketresearch.com/request-for-customization/4586?reqfor=covid

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Meningococcal Vaccines Market analysis, size, share, Covid-19 scenario, Global industry Forecast till 2026

Meningococcal Vaccine Market

Meningococcal Vaccine Market

The global Meningococcal Vaccine Industry is projected to garner $4.19 billion by 2026, witnessing a CAGR of 9.5% from 2019 to 2026.

Increase in outbreaks of meningococcal disease, surge in immunization programs across the globe, and rise in research and development for vaccine technology.”

— Ashish

PUNE, MAHARASHTRA, UNITED STATES, December 1, 2020 /EINPresswire.com/ — The global Meningococcal Vaccine Industry garnered $1.93 billion in 2018, and is projected to garner $4.19 billion by 2026, witnessing a CAGR of 9.5% from 2019 to 2026. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. "Meningococcal Vaccine Market by Serogroup (MenACWY, MenB/BC, MenC, MenAC, and MenA), Vaccine Type (Conjugate, Polysaccharide, and Subcapsular), and End User (Pediatric, Adults, and Travelers): Global Opportunity Analysis and Industry Forecast, 2018–2026."

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/330

Rise in outbreaks of meningococcal disease, increase in immunization programs across the world, and surge in research and development for vaccine technology drive the global meningococcal vaccine market

Covid-19 scenario

Due to lockdown, immunization programs will come to a halt and program schedules will be changed in various countries.

Research and development activities for vaccine technology will be limited, as researchers need to stay at home during the lockdown.

Meningococcal vaccine is used as a placebo effect in the Covid-19 vaccine trial conducted at the University of Oxford.

Get detailed COVID-19 impact analysis on the Meningococcal Vaccine Market @ https://www.alliedmarketresearch.com/request-for-customization/330?reqfor=covid

Based on vaccine serotype, the majority of share was contributed by MenACWY vaccine segment. It accounted for nearly half of the total share in 2018, and is estimated to maintain its lead position during the forecast period. However, the MenA vaccine segment is anticipated to grow at the highest CAGR of 13.5% during the forecast period.

The conjugate segment to maintain its lead by 2026

Based on vaccine type, the conjugate segment held the largest share of the global meningococcal vaccine market, accounting for nearly half of the total market share in 2018, and is estimated to maintain its lead by 2026. Moreover, this segment is estimated to grow at the highest CAGR of 10.2% from 2019 to 2026. This is attributed to usage of vaccines in routine immunization schedules, preventive campaigns, and outbreak responses. The research also analyzes segments including polysachharide and subcapsular.

Leading market players

Bio-Manguinhos
Bio-Med Pvt. Limited
Chongqing Zhifei Biological Products Co., Ltd.
GlaxoSmithKline Plc
Hualan Biological Engineering Inc.
Incepta Pharmaceuticals Ltd.
Pfizer Inc.
Sanofi S.A.
Serum Institute of India Pvt. Ltd.
Walvax Biotechnology Co., Ltd.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/330

Based on region, North America accounted for the largest market share in terms of revenue in 2018, holding nearly half of the global meningococcal vaccine market, and is estimated to maintain its lead position throughout the forecast period. This is due to surge in prevalence of meningitis disease and ease in availability of meningococcal vaccine products for treatment of the disease. However, Asia-Pacific is expected to portray the largest CAGR of 14.7% from 2019 to 2026, owing to surge in outbreaks of meningococcal diseases and widespread availability of products.

Similar Reports:

Orthopedic Devices Market Global Opportunity and Industry Forecast, 2026

Cancer Biomarkers Market Global Opportunity & Industry Forecast, 2027

COPD and Asthma Devices Market Global Opportunity & Industry Forecast, 2027

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+19049962983 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Protein Expression Market To Grow Valuation $4.61 Billion By 2026, At CAGR Of 10.2% | Protein

Protein Expression

The growth in protein expression market is due to rise in prevalence of chronic disease such as diabetes, cancer, autoimmune disorders & cardiovascular diseases

pharmaceutical companies are significantly investing in R&D expenditure thereby propelling the market growth.”

— Mangesh Panhale

PORTLAND, OR, UNITED STATES, December 1, 2020 /EINPresswire.com/ — Protein expression is defined as a biotechnological procedure, which includes generation of precise proteins. These proteins are formed through manipulation of gene expression in organisms of interest. The procedure leads to expression of large amounts of recombinant gene in organisms. Furthermore, this has led to many possibilities of expression and isolation of heterologous proteins for research, clinical, and industrial purposes. This, in turn, has led to advancements in genetic engineering and recombinant technologies. Significant advancements in the field of biotechnology have enabled expression and isolation of recombinant proteins on large scale. Some of products which are used to perform protein expression present in the market include reagents, expression vectors, competent cells, instruments, and others. These products are used in designing therapeutics and conducting research related to medicines.

The global protein expression market is expected to reach $4.61 billion by 2026, registering a CAGR of 10.2% from 2018 to 2026, in terms of value.

To Get the Sample Copy of Report Visit @ https://www.alliedmarketresearch.com/request-sample/6463

The factors that boost the growth of the protein expression market include surge in geriatric population and increase in prevalence of chronic diseases such as cancer. Moreover, increase in spending on protein research also fuel the growth of the protein expression market. However, high monetary inputs associated with the production of protein products restrict the growth of the market. In addition, significant shortage of trained healthcare professionals and lack of local expertise also restrains the market. Conversely, emergence of microfluids, along with growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period.

The Covid-19 outbreak has severely affected every sector across the world. The patient numbers have been increasing every day and the majority of the countries are in complete lockdown. This has affected the supply chain and overall business operations. International trading has taken a significant downfall and has created uncertainty in the stock market. These factors have affected the protein expression market.

The protein expression report offers an in-depth analysis of the Covid-19 impact on various market segments and countries. Moreover, the report offers major market trends and forecasts, considering the Covid-19 situation.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/6463

The global protein expression market is segmented based on product, application, and region.

• Based on product, the market is bifurcated into reagents, expression vectors, competent cells, instruments, and services.
• By application, it is divided into therapeutic, industrial, and research.
• Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, France, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and, rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Access Full Report @ https://www.alliedmarketresearch.com/protein-expression-market-A06098

The Major Key Players Are:

Agilent Technologies, Inc, Becton, Dickinson & Company, Bio Rad Laboratories, GenScript Biotech Corporation, LifeSensors Inc., Merck KGaA, Promega Corporation, QIAGEN N.V., Takara Holdings Inc. and Thermo Fisher Scientific Inc.

Similar Reports:

CHF Treatment Devices Market Analysis and Industry Forecast, 2027

Smart Syringes Market Analysis and Industry Forecast, 2027

Nuclear Medicine Market Analysis and Industry Forecast, 2027

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire